Beijing Tong Ren Tang Chinese Medicine Company Overview
- Status
-
Public
- Employees
-
763
- Stock Symbol
-
03613
- Investments
-
4
- Share Price
-
$0.70
- (As of Friday Closing)
Beijing Tong Ren Tang Chinese Medicine Company General Information
Description
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
Contact Information
Website
cm.tongrentang.comCorporate Office
- 1 Harbour Road
- Wanchai Convention Plaza Office Building, Room 1405-1409
- Hong Kong
- Hong Kong
Corporate Office
- 1 Harbour Road
- Wanchai Convention Plaza Office Building, Room 1405-1409
- Hong Kong
- Hong Kong
Beijing Tong Ren Tang Chinese Medicine Company Stock Performance
As of 13-Nov-2026, Beijing Tong Ren Tang Chinese Medicine Company’s stock price is $0.70. Its current market cap is $583M with 837M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.70 | $0.70 | $0.69 - $1.21 | $583M | 837M | 1.17M | $0.06 |
Beijing Tong Ren Tang Chinese Medicine Company Financials Summary
As of 30-Jun-2026, Beijing Tong Ren Tang Chinese Medicine Company has a trailing 12-month revenue of $173M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 439,277 | 697,747 | 757,081 | 1,023,303 |
| Revenue | 173,256 | 194,112 | 206,535 | 194,776 |
| EBITDA | 65,035 | 72,070 | 85,490 | 89,844 |
| Net Income | 46,152 | 50,949 | 64,111 | 69,023 |
| Total Assets | 575,169 | 598,955 | 587,303 | 567,478 |
| Total Debt | 16,045 | 16,262 | 15,897 | 16,868 |
Beijing Tong Ren Tang Chinese Medicine Company Patents
Beijing Tong Ren Tang Chinese Medicine Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026137640-A1 | Traditional chinese medicine composition for preventing and treating metabolic-associated fatty liver disease, capsule, and use | Pending | 23-Dec-2024 | ||
| WO-2024192708-A1 | Use of ganoderma lucidum active ingredients in preparation of drug for treating skin oxidative damage | Inactive | 22-Mar-2023 | ||
| WO-2024192714-A1 | Use of ganoderma lucidum-containing pharmaceutical composition in preparation for drug for treating lung cancer | Inactive | 22-Mar-2023 | ||
| WO-2024192715-A1 | Use of ganoderma spore powder in preparation of drug for treating melanoma | Inactive | 22-Mar-2023 | ||
| WO-2024192718-A1 | Use of ganoderma-containing pharmaceutical composition in preparation of drug for treating colon cancer | Inactive | 22-Mar-2023 |
Beijing Tong Ren Tang Chinese Medicine Company Signals
Beijing Tong Ren Tang Chinese Medicine Company Investments & Acquisitions (4)
Beijing Tong Ren Tang Chinese Medicine Company’s most recent deal was a Corporate with Tongrentang Maierhai for . The deal was made on 28-Sep-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tongrentang Maierhai | 28-Sep-2021 | Corporate | Pharmaceuticals | ||
| Beijing Tong Ren Tang Giomi | 04-Oct-2018 | Merger/Acquisition | Pharmaceuticals | ||
| Honour Essence Trading | 27-Feb-2015 | Merger/Acquisition | Medical Supplies | ||
| Union Health International | 30-Jun-2014 | Merger/Acquisition | Clinics/Outpatient Services |
Beijing Tong Ren Tang Chinese Medicine Company ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
31.31 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Beijing Tong Ren Tang Chinese Medicine Company Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Union Health International | Hong Kong, Hong Kong | 2004 |
Beijing Tong Ren Tang Chinese Medicine Company FAQs
-
Where is Beijing Tong Ren Tang Chinese Medicine Company headquartered?
Beijing Tong Ren Tang Chinese Medicine Company is headquartered in Hong Kong, Hong Kong.
-
What is the size of Beijing Tong Ren Tang Chinese Medicine Company?
Beijing Tong Ren Tang Chinese Medicine Company has 763 total employees.
-
What industry is Beijing Tong Ren Tang Chinese Medicine Company in?
Beijing Tong Ren Tang Chinese Medicine Company’s primary industry is Pharmaceuticals.
-
Is Beijing Tong Ren Tang Chinese Medicine Company a private or public company?
Beijing Tong Ren Tang Chinese Medicine Company is a Public company.
-
What is Beijing Tong Ren Tang Chinese Medicine Company’s stock symbol?
The ticker symbol for Beijing Tong Ren Tang Chinese Medicine Company is 03613.
-
What is the current stock price of Beijing Tong Ren Tang Chinese Medicine Company?
As of 13-Nov-2026 the stock price of Beijing Tong Ren Tang Chinese Medicine Company is $0.70.
-
What is the current market cap of Beijing Tong Ren Tang Chinese Medicine Company?
The current market capitalization of Beijing Tong Ren Tang Chinese Medicine Company is $583M.
-
What is Beijing Tong Ren Tang Chinese Medicine Company’s current revenue?
The trailing twelve month revenue for Beijing Tong Ren Tang Chinese Medicine Company is $173M.
-
What is Beijing Tong Ren Tang Chinese Medicine Company’s annual earnings per share (EPS)?
Beijing Tong Ren Tang Chinese Medicine Company’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process